SCHEMBL7376134

SCHEMBL7376134

NCCC(=O)ONC(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.56
CA1 P00915 2/20 0.56
CA2 P00918 2/20 0.56
CA9 Q16790 2/20 0.56
HTT P42858 1/20 0.51
ALDH1A1 P00352 3/20 0.50
MAPK1 P28482 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
POLB P06746 1/20 0.48
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
KMT2A Q03164 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
TSHR P16473 1/20 0.46
MGLL Q99685 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27346972 0.93 CA12 (0.59) CA12CA1CA2CA9HTT
SCHEMBL7415486 0.90 CA12 (0.56) CA12CA1CA2CA9HTT
SCHEMBL7105678 0.89 TDP1 (0.57) CA12CA1CA2CA9HTT
SCHEMBL27501720 0.89 CA12 (0.55) CA12CA1CA2CA9HTT
SCHEMBL28337555 0.89 HTT (0.57) CA12CA1CA2CA9HTT
SCHEMBL19692991 0.89 CA12 (0.55) CA12CA1CA2CA9HTT
SCHEMBL8061583 0.88 CA12 (0.54) CA12CA1CA2CA9HTT
SCHEMBL27529913 0.88 CA12 (0.54) CA12CA1CA2CA9HTT
SCHEMBL27592314 0.85 ALDH1A1 (0.66) CA12CA1CA2CA9HTT
SCHEMBL7378816 0.85 CA12 (0.58) CA12CA1CA2CA9HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1049693-A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS Du Pont Pharmaceuticals Company (US) 2000-11-08 EP disclosed
WO-1999026945-A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS αvβ3 ANTAGONISTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-06-03 WO disclosed